Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Daniels

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|November 4, 2011
Collagen implants in hernia repairNeil Smart, Delilah Khan, Ian Daniels
Diseases of the Colon and Rectum|August 14, 2010
Bioprosthetics in parastomal hernia repairRahul Velineni, Neil Smart, Ian Daniels
British Journal of Haematology|June 12, 2008
A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by RituximabIan Daniels, Julie Turzanski, Andrew P Haynes
British Journal of Haematology|February 3, 2009
Involvement of macroautophagy in the caspase-independent killing of Burkitt lymphoma cell lines by rituximabJulie Turzanski, Ian Daniels, Andrew P Haynes
Surgical Innovation|May 28, 2010
Xenograft biologic mesh implantation in abdominal wall reconstruction and the FDA MAUDE databaseBenn Gooch, Neil James Smart, Ian Daniels
Oncology Research|October 22, 2013
Hydroxyurea potentiates the caspase-independent killing of B-cell lines by rituximab and GA101Ian Daniels, Abdulmunem Abulayha, Andrew P Haynes
Leukemia & Lymphoma|September 4, 2008
Internalisation of uncross-linked rituximab is not essential for the induction of caspase-independent killing in Burkitt lymphoma cell linesJulie Turzanski, Ian Daniels, Andrew P Haynes
Diseases of the Colon and Rectum|June 7, 2013
Comments on nonsteroidal anti-inflammatory drugs and anastomotic dehiscenceLuca Bonomo, Rob Bethune, Ian Daniels, et al.
International Journal of Colorectal Disease|May 24, 2014
Evidence for the C-seal device remains inconclusiveAndrea Warwick, Morwena Marshall, Ian Daniels, et al.
Future Oncology (London, England)|December 20, 2014
Rituximab: modes of action, remaining dispute and future perspectiveAbdulmunem Abulayha, Amin Bredan, Hesham El Enshasy, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|November 4, 2011
Collagen implants in hernia repairNeil Smart, Delilah Khan, Ian Daniels
Diseases of the Colon and Rectum|August 14, 2010
Bioprosthetics in parastomal hernia repairRahul Velineni, Neil Smart, Ian Daniels
British Journal of Haematology|June 12, 2008
A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by RituximabIan Daniels, Julie Turzanski, Andrew P Haynes
British Journal of Haematology|February 3, 2009
Involvement of macroautophagy in the caspase-independent killing of Burkitt lymphoma cell lines by rituximabJulie Turzanski, Ian Daniels, Andrew P Haynes
Surgical Innovation|May 28, 2010
Xenograft biologic mesh implantation in abdominal wall reconstruction and the FDA MAUDE databaseBenn Gooch, Neil James Smart, Ian Daniels
Oncology Research|October 22, 2013
Hydroxyurea potentiates the caspase-independent killing of B-cell lines by rituximab and GA101Ian Daniels, Abdulmunem Abulayha, Andrew P Haynes
Leukemia & Lymphoma|September 4, 2008
Internalisation of uncross-linked rituximab is not essential for the induction of caspase-independent killing in Burkitt lymphoma cell linesJulie Turzanski, Ian Daniels, Andrew P Haynes
Diseases of the Colon and Rectum|June 7, 2013
Comments on nonsteroidal anti-inflammatory drugs and anastomotic dehiscenceLuca Bonomo, Rob Bethune, Ian Daniels, et al.
International Journal of Colorectal Disease|May 24, 2014
Evidence for the C-seal device remains inconclusiveAndrea Warwick, Morwena Marshall, Ian Daniels, et al.
Future Oncology (London, England)|December 20, 2014
Rituximab: modes of action, remaining dispute and future perspectiveAbdulmunem Abulayha, Amin Bredan, Hesham El Enshasy, et al.
Pageof 3